162 related articles for article (PubMed ID: 18624839)
1. Palmoplantar psoriasis: a paradoxical adverse reaction induced by adalimumab.
Bordel-Gómez MT; Sánchez-Estella J; Martínez-González O; Cardeñoso-Alvarez ME
J Eur Acad Dermatol Venereol; 2009 Apr; 23(4):444-5. PubMed ID: 18624839
[No Abstract] [Full Text] [Related]
2. First case report of adalimumab-induced psoriasis in Crohn's disease.
Harris MD; Richards R
Am J Gastroenterol; 2009 Mar; 104(3):792-3. PubMed ID: 19262532
[No Abstract] [Full Text] [Related]
3. Palmoplantar and scalp psoriasis occurring during anti-tumour necrosis factor-alpha therapy: a case series of four patients and guidelines for management.
Papadavid E; Gazi S; Dalamaga M; Stavrianeas N; Ntelis V
J Eur Acad Dermatol Venereol; 2008 Mar; 22(3):380-2. PubMed ID: 18269613
[No Abstract] [Full Text] [Related]
4. Ustekinumab treatment of TNF antagonist-induced paradoxical psoriasis flare in a patient with psoriatic arthritis: case report and review.
Puig L; Morales-Múnera CE; López-Ferrer A; Geli C
Dermatology; 2012; 225(1):14-7. PubMed ID: 22890275
[TBL] [Abstract][Full Text] [Related]
5. Pustular psoriasis following treatment of rheumatoid arthritis with TNF-alpha inhibitors.
Egnatios G; Warthan MM; Pariser R; Hood AF
J Drugs Dermatol; 2008 Oct; 7(10):975-7. PubMed ID: 19112764
[No Abstract] [Full Text] [Related]
6. Adalimumab-induced psoriasis of the scalp with diffuse alopecia: a severe potentially irreversible cutaneous side effect of TNF-alpha blockers.
El Shabrawi-Caelen L; La Placa M; Vincenzi C; Haidn T; Muellegger R; Tosti A
Inflamm Bowel Dis; 2010 Feb; 16(2):182-3. PubMed ID: 19462433
[No Abstract] [Full Text] [Related]
7. Psoriasis induced by anti-tumor necrosis factor therapy: a paradoxical adverse reaction.
Sfikakis PP; Iliopoulos A; Elezoglou A; Kittas C; Stratigos A
Arthritis Rheum; 2005 Aug; 52(8):2513-8. PubMed ID: 16052599
[TBL] [Abstract][Full Text] [Related]
8. TNF-α inhibitor (adalimumab) induced psoriasis: a case report.
Al-Mutairi A; Elkashlan M; Al-Fayed HM; Swayed M
Australas J Dermatol; 2012 May; 53(2):157. PubMed ID: 22571571
[No Abstract] [Full Text] [Related]
9. Five cases of anti-tumor necrosis factor alpha-induced psoriasis presenting with severe scalp involvement in children.
Perman MJ; Lovell DJ; Denson LA; Farrell MK; Lucky AW
Pediatr Dermatol; 2012; 29(4):454-9. PubMed ID: 21995665
[TBL] [Abstract][Full Text] [Related]
10. Infliximab-induced palmoplantar psoriasis in a patient with ankylosing spondylitis.
Capkin E; Karkucak M; Yayli S; Aydin Çapkin A; Tosun M
J Clin Rheumatol; 2011 Aug; 17(5):293-4. PubMed ID: 21808187
[No Abstract] [Full Text] [Related]
11. [Flexural psoriasis induced by infliximab and adalimumab in a patient with Crohn's disease].
Avila Alvarez A; García-Alonso L; Solar Boga A; García-Silva J
An Pediatr (Barc); 2009 Mar; 70(3):278-81. PubMed ID: 19409245
[TBL] [Abstract][Full Text] [Related]
12. Treatment of psoriasis with adalimumab.
Pitarch G; Sanchez-Carazo JL; Mahiques L; Perez-Ferriols MA; Fortea JM
Clin Exp Dermatol; 2007 Jan; 32(1):18-22. PubMed ID: 17305904
[TBL] [Abstract][Full Text] [Related]
13. Psoriasis and palmoplantar pustulosis associated with tumor necrosis factor-α inhibitors: the Mayo Clinic experience, 1998 to 2010.
Shmidt E; Wetter DA; Ferguson SB; Pittelkow MR
J Am Acad Dermatol; 2012 Nov; 67(5):e179-85. PubMed ID: 21752492
[TBL] [Abstract][Full Text] [Related]
14. Adalimumab desensitization after anaphylactic reaction.
Quercia O; Emiliani F; Foschi FG; Stefanini GF
Ann Allergy Asthma Immunol; 2011 Jun; 106(6):547-8. PubMed ID: 21624763
[No Abstract] [Full Text] [Related]
15. The therapeutic potential of TNF-alpha antagonists for skin psoriasis comorbidities.
Piérard GE; Piérard-Franchimont C; Szepetiuk G; Paquet P; Quatresooz P
Expert Opin Biol Ther; 2010 Aug; 10(8):1197-208. PubMed ID: 20560729
[TBL] [Abstract][Full Text] [Related]
16. Adalimumab in the management of palmoplantar psoriasis.
Ghate JV; Alspaugh CD
J Drugs Dermatol; 2009 Dec; 8(12):1136-9. PubMed ID: 20027943
[TBL] [Abstract][Full Text] [Related]
17. Onset of psoriasis during treatment with TNF-{alpha} antagonists: a report of 3 cases.
Ubriani R; Van Voorhees AS
Arch Dermatol; 2007 Feb; 143(2):270-2. PubMed ID: 17310016
[No Abstract] [Full Text] [Related]
18. "Paradoxical" adverse effects caused by anti-tumor necrosis factor-α biological drugs: appearance of psoriasis in a patient treated with infliximab for rheumatoid arthritis.
Satriano RA; Abbate G; Esposito S; Cassaglia B; Piccolo V; Baroni A
Indian J Dermatol Venereol Leprol; 2011; 77(4):536. PubMed ID: 21727719
[No Abstract] [Full Text] [Related]
19. Tumour necrosis factor-α antagonists in patients with concurrent psoriasis and hepatitis B or hepatitis C: a retrospective analysis of 17 patients.
Prignano F; Ricceri F; Pescitelli L; Zanieri F; Lotti T
Br J Dermatol; 2011 Mar; 164(3):645-7. PubMed ID: 21375517
[TBL] [Abstract][Full Text] [Related]
20. Psoriasis induced by anti-tumour necrosis factor therapy in patients with inflammatory bowel disease.
Salgueiro P; Lago P; Pedroto I
J Crohns Colitis; 2013 Sep; 7(8):e325-6. PubMed ID: 23352103
[No Abstract] [Full Text] [Related]
[Next] [New Search]